Key facts
- It has raised $3.5M; the latest was Seed Round ($3.5M) in Dec 2024.
- Notable investors include Front Row Ventures, Providence Health Care Ventures, Health Innovation Hub.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for MyTrials.ai
- ·The full record, as it builds
Funding rounds
No funding rounds for MyTrials.ai are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MyTrials.ai
Developer of an AI-powered clinical trial matching platform designed to connect patients with studies that match their health profiles, preferences, and values. The company's platform provides streamlined tools for identifying eligible participants, reducing recruitment timelines, and improving trial outcomes, to match individuals with suitable clinical trials, enabling researchers and clinical trial organizations to simplify enrollment and enhancing access to potentially life-saving treatments.
- Sector
- Healthcare
- HQ
- Vancouver, Canada
- Founded
- 2024
- Employees
- 4
- Website
- mytrials.ai/
- Ownership
- Privately Held (backing)
MyTrials.ai doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MyTrials.ai shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MyTrials.ai in its N-PORT filings yet. We sweep new filings monthly.